Mary-Jane Attenburrow

1.4k total citations
28 papers, 631 citations indexed

About

Mary-Jane Attenburrow is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Mary-Jane Attenburrow has authored 28 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in Mary-Jane Attenburrow's work include Bipolar Disorder and Treatment (7 papers), Cardiovascular Health and Risk Factors (6 papers) and Tryptophan and brain disorders (4 papers). Mary-Jane Attenburrow is often cited by papers focused on Bipolar Disorder and Treatment (7 papers), Cardiovascular Health and Risk Factors (6 papers) and Tryptophan and brain disorders (4 papers). Mary-Jane Attenburrow collaborates with scholars based in United Kingdom, China and Austria. Mary-Jane Attenburrow's co-authors include Philip J. Cowen, J. Odontiadis, J.M. Elliott, Ann L. Sharpley, John Geddes, Andrea Cipriani, Paul J. Harrison, Jane Powell, Clare Williams and Catherine J. Harmer and has published in prestigious journals such as American Journal of Psychiatry, Psychological Medicine and Neuropsychopharmacology.

In The Last Decade

Mary-Jane Attenburrow

26 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary-Jane Attenburrow United Kingdom 14 191 141 127 123 93 28 631
Dorottya Pap Hungary 16 165 0.9× 106 0.8× 125 1.0× 107 0.9× 91 1.0× 34 623
Riccardo Guglielmo Italy 13 166 0.9× 126 0.9× 108 0.9× 110 0.9× 144 1.5× 29 601
M. Picchetti Italy 11 168 0.9× 108 0.8× 170 1.3× 95 0.8× 105 1.1× 22 709
S. De Risio Italy 16 137 0.7× 173 1.2× 120 0.9× 139 1.1× 157 1.7× 26 625
Nicolás A. Núñez United States 14 265 1.4× 103 0.7× 65 0.5× 94 0.8× 138 1.5× 55 711
Christian Barnas Austria 13 230 1.2× 78 0.6× 69 0.5× 115 0.9× 101 1.1× 25 515
Krisztina Mekli United Kingdom 15 109 0.6× 74 0.5× 72 0.6× 121 1.0× 134 1.4× 24 736
Thomas Stamm Germany 17 364 1.9× 122 0.9× 78 0.6× 63 0.5× 179 1.9× 42 698
Marie‐Josée Filteau Canada 6 190 1.0× 111 0.8× 88 0.7× 78 0.6× 228 2.5× 7 539
Ronald Landbloom United States 11 203 1.1× 110 0.8× 65 0.5× 144 1.2× 89 1.0× 15 598

Countries citing papers authored by Mary-Jane Attenburrow

Since Specialization
Citations

This map shows the geographic impact of Mary-Jane Attenburrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary-Jane Attenburrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary-Jane Attenburrow more than expected).

Fields of papers citing papers by Mary-Jane Attenburrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary-Jane Attenburrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary-Jane Attenburrow. The network helps show where Mary-Jane Attenburrow may publish in the future.

Co-authorship network of co-authors of Mary-Jane Attenburrow

This figure shows the co-authorship network connecting the top 25 collaborators of Mary-Jane Attenburrow. A scholar is included among the top collaborators of Mary-Jane Attenburrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary-Jane Attenburrow. Mary-Jane Attenburrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henshall, Catherine, et al.. (2022). Examining the Effectiveness of Web-Based Interventions to Enhance Resilience in Health Care Professionals: Systematic Review. JMIR Medical Education. 8(3). e34230–e34230. 13 indexed citations
2.
Xie, Chunyan, et al.. (2022). [Current status of regular exercise and influencing factors in 18-64 year old labor force population in Beijing].. PubMed. 43(3). 373–379. 3 indexed citations
3.
Attenburrow, Mary-Jane, Maigeng Zhou, Xinying Zeng, & Dong Zhao. (2021). [The current status and trend of disease burden of neoplasms in 1990 and 2016 for Beijing people].. PubMed. 43(3). 351–356. 1 indexed citations
4.
Jagannath, Aarti, Justyn M. Thomas, Grant C. Churchill, et al.. (2020). Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder. Molecular Psychiatry. 26(9). 5252–5265. 16 indexed citations
5.
Attenburrow, Mary-Jane, Jing Dong, Kai Fang, et al.. (2020). [Comprehensive control rate and related factros of diabetes mellitus in Beijing].. PubMed. 54(11). 1283–1288. 2 indexed citations
6.
Jiang, Bo, Mary-Jane Attenburrow, Chunyan Xie, et al.. (2020). [Study on intention of smoking concession, awareness of smoking hazards and impact on smoking status in residents aged 18-65 years in Beijing].. PubMed. 41(7). 1058–1062. 2 indexed citations
7.
Goodday, Sarah, Lauren Atkinson, Guy M. Goodwin, et al.. (2019). The True Colours Remote Symptom Monitoring System: A Decade of Evolution. Journal of Medical Internet Research. 22(1). e15188–e15188. 26 indexed citations
8.
Marwood, Lindsey, R. Taylor, Kimberley Goldsmith, et al.. (2017). Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study). BMC Psychiatry. 17(1). 231–231. 14 indexed citations
9.
Henshall, Catherine, Lisa Marzano, Katharine Smith, et al.. (2017). A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers. BMC Psychiatry. 17(1). 265–265. 29 indexed citations
10.
Attenburrow, Mary-Jane, et al.. (2016). [Current smoking status and awareness of tobacco hazard in adults in Beijing, 2014].. PubMed. 37(9). 1233–1237. 3 indexed citations
11.
12.
Cipriani, Andrea, Kate Saunders, Mary-Jane Attenburrow, et al.. (2016). A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Molecular Psychiatry. 21(10). 1324–1332. 73 indexed citations
13.
Geddes, John, Jennifer Rendell, Merryn Voysey, et al.. (2015). Newcastle University ePrints (Newcastle Univesity). 47 indexed citations
14.
Geddes, John, Jennifer Rendell, Andrea Cipriani, et al.. (2015). Rationale and design of OxLith: a randomised placebo controlled trial exploring the short-term physical and psychological effects of lithium on mood instability. Bipolar Disorders. 17. 110–110. 1 indexed citations
15.
Attenburrow, Mary-Jane, et al.. (2004). Comparison of the Effects of Citalopram and Escitalopram on 5-Ht-Mediated Neuroendocrine Responses. Neuropsychopharmacology. 29(9). 1699–1703. 41 indexed citations
16.
Attenburrow, Mary-Jane, Clare Williams, J. Odontiadis, et al.. (2003). Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology. 169(1). 104–107. 75 indexed citations
17.
Attenburrow, Mary-Jane, Clare Williams, J. Odontiadis, et al.. (2003). The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychological Medicine. 33(8). 1381–1386. 22 indexed citations
18.
Attenburrow, Mary-Jane, J. Odontiadis, Brian J. Murray, Philip J. Cowen, & M. Franklin. (2002). Chromium treatment decreases the sensitivity of 5-HT 2A receptors. Psychopharmacology. 159(4). 432–436. 42 indexed citations
19.
Attenburrow, Mary-Jane, et al.. (2001). Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology. 155(3). 323–326. 67 indexed citations
20.
Silverstone, Peter H., et al.. (1992). The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients. International Clinical Psychopharmacology. 7(2). 87–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorottya Pap Breakdown of academic impact, for papers by Riccardo Guglielmo Breakdown of academic impact, for papers by M. Picchetti Breakdown of academic impact, for papers by S. De Risio Breakdown of academic impact, for papers by Nicolás A. Núñez Breakdown of academic impact, for papers by Christian Barnas Breakdown of academic impact, for papers by Krisztina Mekli Breakdown of academic impact, for papers by Thomas Stamm Breakdown of academic impact, for papers by Marie‐Josée Filteau Breakdown of academic impact, for papers by Ronald Landbloom
Rankless by CCL
2026